Kazuhiko Fujii
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kazuhiko Fujii has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Hidenori Ichiyasu
Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan
2 shared publications - Hirotsugu Kohrogi
Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan
2 shared publications - Keisuke Kojima
Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto 860-8556, Japan
2 shared publications - Shinichiro Okamoto
Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
2 shared publications - Chieko Yoshida
Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
1 shared publication Chihiro Motozono
Division of Infection and immunity, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto 860-0811, Japan
1 shared publication
Latest Publications
- Open Access
- 1 July 2021
- Published by Elsevier in Cell Reports
- Vol. 36 (2) , 109385
Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19
- 1 July 2021
- Published by Elsevier in Cell Reports
- Vol. 36 (2) , 109385
Open AccessResistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19
- Open Access
- 11 September 2017
- Published by Wiley in Clinical Case Reports
- Vol. 5 (10) , 1732-1733
Granulomatosis with polyangiitis can cause periaortitis and pericarditis
Key Clinical Message: Granulomatosis with polyangiitis (GPA) is characterized by necrotizing granulomatous inflammation usually involving the upper and lower respiratory tracts and necrotizing vasculitis predominantly affecting small‐sized vessels. Although categorized as a small vessel vasculitis, GPA can cause periaortitis and pericarditis. Physicians should recognize all categories of vasculitis can affect any size arteries.
- 11 September 2017
- Published by Wiley in Clinical Case Reports
- Vol. 5 (10) , 1732-1733
Open AccessGranulomatosis with polyangiitis can cause periaortitis and pericarditis
Key Clinical Message: Granulomatosis with polyangiitis (GPA) is characterized by necrotizing granulomatous inflammation usually involving the upper and lower respiratory tracts and necrotizing vasculitis predominantly affecting small‐sized vessels. Although categorized as a small vessel vasculitis, GPA can cause periaortitis and pericarditis. Physicians should recognize all categories of vasculitis can affect any size arteries.
- Open Access
- 13 November 2014
- Published by Wiley in Case Reports in Pulmonology
- Vol. 2014, 1-3
Cisplatin-Induced Eosinophilic Pneumonia
A 67-year-old man suffering from esophageal cancer was admitted to our hospital complaining of dyspnea and hypoxemia. He had been treated with cisplatin, docetaxel, and fluorouracil combined with radiotherapy. Chest computed tomography revealed bilateral ground-glass opacity, and bronchoalveolar lavage fluid showed increased eosinophils. Two episodes of transient eosinophilia in peripheral blood were observed after serial administration of anticancer drugs before the admission, and drug-induced lymphocyte stimulation test to cisplatin was positive. Thus cisplatin-induced eosinophilic pneumonia was suspected, and corticosteroid was effectively administered. To our knowledge, this is the first reported case of cisplatin-induced eosinophilic pneumonia.
- 13 November 2014
- Published by Wiley in Case Reports in Pulmonology
- Vol. 2014, 1-3
Open AccessCisplatin-Induced Eosinophilic Pneumonia
A 67-year-old man suffering from esophageal cancer was admitted to our hospital complaining of dyspnea and hypoxemia. He had been treated with cisplatin, docetaxel, and fluorouracil combined with radiotherapy. Chest computed tomography revealed bilateral ground-glass opacity, and bronchoalveolar lavage fluid showed increased eosinophils. Two episodes of transient eosinophilia in peripheral blood were observed after serial administration of anticancer drugs before the admission, and drug-induced lymphocyte stimulation test to cisplatin was positive. Thus cisplatin-induced eosinophilic pneumonia was suspected, and corticosteroid was effectively administered. To our knowledge, this is the first reported case of cisplatin-induced eosinophilic pneumonia.